276 related articles for article (PubMed ID: 8543839)
1. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. Potential for idiotype immunization against HIV.
Sutor GC; Dreikhausen U; Vähning U; Jurkiewicz E; Hunsmann G; Lundin K; Schedel I
J Immunol; 1992 Aug; 149(4):1452-61. PubMed ID: 1500724
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
Boudet F; Theze J; Zouali M
Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
[TBL] [Abstract][Full Text] [Related]
4. A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization.
Healey DG; Dianda L; Buck D; Schroeder K; Truneh A; Sattentau QJ; Beverley PC
Eur J Immunol; 1991 Jun; 21(6):1491-8. PubMed ID: 1710569
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4.
Corre JP; Février M; Chamaret S; Thèze J; Zouali M
Eur J Immunol; 1991 Mar; 21(3):743-51. PubMed ID: 1672646
[TBL] [Abstract][Full Text] [Related]
6. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
Connelly RJ; Kahn M; Blake J; Haffar OK; Thomas EK
Virology; 1994 Dec; 205(2):554-7. PubMed ID: 7526543
[TBL] [Abstract][Full Text] [Related]
7. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
8. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
9. Detection of T cell CD4 epitopes in HIV-infected individuals.
Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F
Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
[TBL] [Abstract][Full Text] [Related]
11. [Post infection antiidiotype vaccination against HIV: results of a phase Ia pilot study].
Schedel I; Sutor GC; Jurkiewicz E; Hunsmann G; Lundin K; Hirn M
Immun Infekt; 1993 Apr; 21 Suppl 1():49-51. PubMed ID: 8344693
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses.
Morrow WJ; Williams WM; Whalley AS; Ryskamp T; Newman R; Kang CY; Chamat S; Köhler H; Kieber-Emmons T
Immunology; 1992 Apr; 75(4):557-64. PubMed ID: 1592430
[TBL] [Abstract][Full Text] [Related]
14. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. I. Cross-reacting idiotopes are expressed in subpopulations of HIV-infected individuals.
Müller S; Wang HT; Kaveri SV; Chattopadhyay S; Köhler H
J Immunol; 1991 Aug; 147(3):933-41. PubMed ID: 1861082
[TBL] [Abstract][Full Text] [Related]
15. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site.
Chamat S; Nara P; Berquist L; Whalley A; Morrow WJ; Köhler H; Kang CY
J Immunol; 1992 Jul; 149(2):649-54. PubMed ID: 1378074
[TBL] [Abstract][Full Text] [Related]
16. A "network antigen" for human CD4. A murine monoclonal anti-idiotype to Leu-3a induces an anti-CD4 response in naive mice.
Healey DG; Dianda L; Beverley PC
J Immunol; 1992 Feb; 148(3):821-6. PubMed ID: 1370519
[TBL] [Abstract][Full Text] [Related]
17. Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins.
Sugiura W; Broder CC; Moss B; Earl PL
Virology; 1999 Feb; 254(2):257-67. PubMed ID: 9986792
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients.
Chams V; Idziorek T; Klatzmann D
AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809
[TBL] [Abstract][Full Text] [Related]
19. Anti-Leu3a induces combining site-related anti-idiotypic antibody without inducing anti-HIV activity.
Reeves JP; Buck D; Berkower I; Murphy D; Epstein SL
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):55-63. PubMed ID: 2015115
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
